CONTACT US: Contact info
|
Citation |
Holla B, Gowda GS, Prabhu L, Baby S, Viswanath B, Chand P, Murthy P. Asian J. Psychiatry 2015; 17: 99-100. |
|
Affiliation |
Centre of Addiction Medicine, Department of Psychiatry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bangalore 560029, India. |
|
Copyright |
(Copyright © 2015, Elsevier Publishing) |
|
DOI |
|
PMID |
26264491 |
|
Abstract |
Baclofen is increasingly being used as an off label anti-craving agent in alcohol use disorders in various parts of the world. The lack of proper recommendations regarding the dosage has important implications for safety in clinical management. In this context, we report two patients who were started with Baclofen as an anti-craving agent, and later developed serious complications following acute self inflicted overdose. We also highlight the important mechanisms of such complications and precautions that needs to be exerted while prescribing. Language: en |